VS
Vedprakash Shantalingappa Ragate
About Vedprakash Shantalingappa Ragate
Data last updated:
Vedprakash Shantalingappa Ragate was a Director at Alivira Animal Health Limited (2024–2025), Whole-Time Director at Sequent Scientific Limited (2024–2025) and Director at Sequent Research Limited (from 2024). The companies operate in Pharma and Chemicals.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 06 Apr 2024 | 2013 | ₹393 Cr (FY 2025) | Active | |
| Whole-Time Director | 17 Apr 2024 | 1985 | ₹3,464 Cr (FY 2026) | Active | |
| Director | 11 Apr 2024 | 2007 | ₹9.52 Cr (FY 2025) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vedprakash Shantalingappa Ragate
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vedprakash Shantalingappa Ragate
Vedprakash Shantalingappa Ragate was first appointed on 06 Apr 2024 as Director at Alivira Animal Health Limited.
Vedprakash Shantalingappa Ragate held 3 earlier board appointments: Alivira Animal Health Limited (Director, 06 Apr 2024 to 30 Sep 2025); Sequent Scientific Limited (Whole-Time Director, 17 Apr 2024 to 30 Sep 2025); Sequent Research Limited (Director, from 11 Apr 2024).